Masato Nakamura
About
In The Last Decade
Masato Nakamura
462 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 185
- Cardiology and Cardiovascular Medicine 3.5k
- Surgery 3.4k
- Pulmonary and Respiratory Medicine 1.6k
- Radiology, Nuclear Medicine and Imaging 1.5k
- Materials Chemistry 694
Countries citing papers authored by Masato Nakamura
This map shows the geographic impact of Masato Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Nakamura more than expected).
Fields of papers citing papers by Masato Nakamura
This network shows the impact of papers produced by Masato Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Nakamura. The network helps show where Masato Nakamura may publish in the future.
Co-authorship network of co-authors of Masato Nakamura
This figure shows the co-authorship network connecting the top 25 collaborators of Masato Nakamura. A scholar is included among the top collaborators of Masato Nakamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Nakamura. Masato Nakamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 46 | |
| 7 | 1 | |
| 8 | 76 | |
| 9 | Mid-term results of everolimus-eluting stent in a Japanese population compared with a US randomized cohort: SPIRIT III Japan Registry with harmonization by doing. | 5 |
| 10 | PJ-046 Impact of Abnormal Glucose Tolerance on Angiographically Silent Coronary Atherosclerosis : An Intravascular Ultrasound Study(Atherosclerosis, clinical(09)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) | 0 |
| 11 | MULTISCALE ANALYSIS OF BLOOD FLOW: MODELING AND SIMULATION OF MULTIPLE RED BLOOD CELL FLOW | 1 |
| 12 | The impact of cutting balloon angioplasty for the treatment of diffuse in-stent restenosis. | 7 |
| 13 | 1 | |
| 14 | Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme. | 12 |
| 15 | 29 | |
| 16 | Multidrug resistance-associated protein and mutant p53 protein expression in non-small cell lung cancer. | 45 |
| 17 | In vitro and in vivo antibacterial activities of sparfloxacin, a new quinolone | 4 |
| 18 | 1 | |
| 19 | Metabolic fate of TE-031 (A-56268). (VIII). Absorption and excretion in humans (bioassay) | 9 |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.